Atopic Dermatitis Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.
STUDY VISITS
+
PATIENTS
+
DERMATOLOGISTS
+
Atopic dermatitis registry site map

Participating Sites

CorEvitas has atopic dermatitis clinical sites across the U.S. and we are always interested in expanding the registry for qualified sites.

LEARN MORE

Outcome measures in the CorEvitas Atopic Dermatitis Registry.

In addition to demographics, clinical features, medication history and changes, and comorbidities, key outcome measures collected include:

Clinician Reported Outcomes

  • Body Surface Area (BSA) Involvement
  • Eczema Area and Severity Index (EASI)
  • SCORing Atopic Dermatitis (SCORAD)
  • Validated Investigator Global Assessment scale for Atopic Dermatitis (vIGA-AD)
  • Nail changes due to atopic dermatitis (graduated Visual Analogue Scale)

Patient Reported Outcomes

  • Patient global assessments of disease control and severity
  • Dermatology Life Quality Index (DLQI)
  • Patient-Oriented Eczema Measure (POEM)
  • Atopic Dermatitis Control Tool (ADCT)
  • Peak pruritus Numerical Rating Scale
  • Sleeplessness and average pruritus (SCORAD)
  • Skin Pain Numerical Rating Scale
  • Fatigue Numerical Rating Scale
  • Itch triggers (PROMIS)
  • Work Productivity and Activity Impairment (WPAI)
Active safety assessments using structured data fields are collected with supporting documents to meet regulatory requirements and post marketing commitments of manufacturers.

Registry Scientific Advisors

Picture of Jonathan Silverberg, MD, PhD, MPH, FAAD

Jonathan Silverberg, MD, PhD, MPH, FAAD

Professor of Dermatology, George Washington University School of Medicine and Health Sciences in Washington, DC

Picture of Eric Simpson, MD, MCR

Eric Simpson, MD, MCR

Professor of Dermatology, School of Medicine, Oregon Health & Science University, Portland, Oregon

Saturday September 7, 2019

Our Publications

MANUSCRIPTS AND ABSTRACTS

Other Registries

Question about a registry?

Contact Us